Belgium Cancer Research
European Clinical Trials Hub & Universal CAR-T Pioneer
EORTC Clinical Trials
35 countries
Pediatric Survival Rate
World-class outcomes
Genomic Profiling Access
All cancer patients
European Clinical Trials Headquarters (EORTC)
European Organization for Research and Treatment of Cancer (EORTC) headquartered in Brussels coordinates 1,500+ cancer clinical trials across 35 countries, world's largest multinational trials network.
Impact:
Coordinating Europe's cancer research ecosystem
CAR-T Therapy Innovation Hub
Belgium's Ghent University and KU Leuven pioneered universal CAR-T cells (off-the-shelf) eliminating 3-week manufacturing wait, making therapy available immediately for emergency cases.
Impact:
Instant CAR-T therapy availability
Proton Therapy Center of Excellence
Belgium operates Europe's most advanced proton therapy center (IBA Proteus ONE) treating 1,000+ patients annually with pencil-beam scanning precision unavailable elsewhere.
Impact:
Ultra-precise radiation therapy
Cancer Immunotherapy Leadership
Belgian researchers at VIB-UGent discovered key immune checkpoint mechanisms, contributing to development of 5+ FDA-approved immunotherapy drugs including nivolumab pathways.
Impact:
Foundation of modern immunotherapy
Liquid Biopsy Technology Pioneer
Belgium's Genomic Vision and multiple academic centers developed blood tests detecting cancer mutations with 98%+ accuracy, approved for clinical use across EU.
Impact:
Non-invasive cancer diagnosis and monitoring
Pediatric Cancer Research Excellence
Belgium achieves 85%+ childhood cancer survival rates through national pediatric oncology network coordinating treatment across all hospitals, among world's best outcomes.
Impact:
Saving children's lives with world-class care
Precision Medicine Integration
Belgium implemented nationwide genomic profiling for all cancer patients through public healthcare, providing personalized treatment recommendations to 100% of patients.
Impact:
Universal precision oncology
Universal Healthcare Cancer Success
Belgium's healthcare system achieves 65%+ 5-year cancer survival with equitable access for all citizens, proving comprehensive coverage delivers excellent results.
Impact:
Model for accessible cancer care
European Organization for Research and Treatment of Cancer (EORTC)
Brussels
World's largest multinational cancer trials organization. Coordinates 1,500+ trials across 35 countries, setting standards for cancer research globally.
Key Specialties:
KU Leuven Cancer Institute
Leuven
Belgium's premier cancer research center. Leading CAR-T innovation, proton therapy, and precision oncology. 1,000+ researchers.
Key Specialties:
VIB (Flanders Institute for Biotechnology)
Ghent, Brussels
World-class life sciences research institute. Breakthrough discoveries in cancer immunology, genomics, and drug development.
Key Specialties:
Institut Jules Bordet
Brussels
Leading comprehensive cancer center. Excellence in breast cancer research, immunotherapy, and clinical trials. 8,000+ patients annually.
Key Specialties:
Belgium welcomes international patients to cutting-edge clinical trials
Universal Off-the-Shelf CAR-T
Ready-to-use CAR-T cells requiring no patient-specific manufacturing, available immediately for emergency blood cancer cases.
Precision Proton Beam Therapy
Ultra-precise pencil-beam proton therapy for brain, spine, and pediatric cancers minimizing radiation to healthy tissue.
Liquid Biopsy Monitoring Program
Blood test monitoring for cancer recurrence and treatment response across multiple cancer types with 98%+ accuracy.
EORTC Multi-National Immunotherapy Trials
Pan-European trials testing novel immunotherapy combinations for melanoma, lung, and kidney cancers across 35 countries.
Registry-listed trials for Belgium currently tracked in our database, sourced from public trial registries.
